Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.

Lopez-Aguiar AG, Ethun CG, Pawlik TM, Tran T, Poultsides GA, Isom CA, Idrees K, Krasnick BA, Fields RC, Salem A, Weber SM, Martin RCG, Scoggins CR, Shen P, Mogal HD, Beal EW, Schmidt C, Shenoy R, Hatzaras I, Maithel SK.

Ann Surg Oncol. 2019 Mar 15. doi: 10.1245/s10434-019-07306-x. [Epub ahead of print]

PMID:
30877497
2.

Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.

Lopez-Aguiar AG, Ethun CG, McInnis MR, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal EW, Hatzaras I, Shenoy R, Cardona K, Maithel SK.

J Surg Oncol. 2018 Jun;117(8):1638-1647. doi: 10.1002/jso.25086. Epub 2018 May 14.

PMID:
29761515
3.

Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative.

Squires MH 3rd, Kooby DA, Poultsides GA, Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI, Schmidt CR, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Levine EA, Jin LX, Cho CS, Winslow ER, Russell MC, Staley CA, Maithel SK.

J Am Coll Surg. 2015 Sep;221(3):767-77. doi: 10.1016/j.jamcollsurg.2015.06.012. Epub 2015 Jun 21.

PMID:
26228017
4.

Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.

Poorman CE, Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK.

Am Surg. 2017 Jul 1;83(7):761-768.

5.

Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.

Yang T, Lu JH, Lau WY, Zhang TY, Zhang H, Shen YN, Alshebeeb K, Wu MC, Schwartz M, Shen F.

J Hepatol. 2016 Mar;64(3):583-93. doi: 10.1016/j.jhep.2015.10.012. Epub 2015 Oct 24.

PMID:
26596543
6.

Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.

Dekker AM, Wiggers JK, Coelen RJ, van Golen RF, Besselink MG, Busch OR, Verheij J, Hollmann MW, van Gulik TM.

HPB (Oxford). 2016 Mar;18(3):262-70. doi: 10.1016/j.hpb.2015.08.004. Epub 2016 Jan 6.

7.

The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.

Hallet J, Tsang M, Cheng ES, Habashi R, Kulyk I, Hanna SS, Coburn NG, Lin Y, Law CH, Karanicolas PJ.

Ann Surg Oncol. 2015 Nov;22(12):4038-45. doi: 10.1245/s10434-015-4477-4. Epub 2015 Mar 10.

PMID:
25752895
8.

Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?

Janssen SJ, Braun Y, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, Schwab JH.

Clin Orthop Relat Res. 2015 Jul;473(7):2343-51. doi: 10.1007/s11999-015-4167-3. Epub 2015 Jan 31.

9.

The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.

Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM.

Ann Surg Oncol. 2015 Nov;22(12):4020-8. doi: 10.1245/s10434-015-4472-9. Epub 2015 Mar 12.

PMID:
25762481
10.

Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.

Ethun CG, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Idrees K, Fields RC, Weber SM, Cho C, Martin RC, Scoggins CR, Shen P, Schmidt C, Hatzaras I, Bentrem D, Ahmad S, Abbott D, Kim HJ, Merchant N, Staley CA, Kooby DA, Maithel SK.

J Am Coll Surg. 2017 Apr;224(4):406-413. doi: 10.1016/j.jamcollsurg.2016.12.006. Epub 2016 Dec 23.

PMID:
28017812
11.

Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.

Krasnick BA, Jin LX, Davidson JT 4th, Sanford DE, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Hawkins WG, Chapman WC, Doyle MBM, Weber SM, Strasberg SM, Salem A, Martin RCG, Isom CA, Scoggins C, Schmidt CR, Shen P, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.

J Surg Oncol. 2018 Mar;117(3):363-371. doi: 10.1002/jso.24836. Epub 2017 Dec 28.

12.

Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection.

Maithel SK, Coban I, Kneuertz PJ, Kooby DA, El-Rayes BF, Kauh JS, Sarmiento J, Staley CA 3rd, Volkan Adsay N.

Ann Surg Oncol. 2011 Sep;18(9):2699-705. doi: 10.1245/s10434-011-1610-x. Epub 2011 Mar 1.

PMID:
21360249
13.

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.

Zhou PY, Tang Z, Liu WR, Tian MX, Jin L, Jiang XF, Wang H, Tao CY, Ding ZB, Peng YF, Qiu SJ, Dai Z, Zhou J, Fan J, Shi YH.

BMC Cancer. 2017 Nov 14;17(1):762. doi: 10.1186/s12885-017-3745-z.

14.

Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.

Zhang XF, Beal EW, Chakedis J, Chen Q, Lv Y, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Buettner S, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM.

World J Surg. 2018 Sep;42(9):2919-2929. doi: 10.1007/s00268-018-4530-0.

PMID:
29404753
15.

Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.

Postlewait LM, Ethun CG, Le N, Pawlik TM, Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RCG, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Vitiello G, Cardona K, Maithel SK.

HPB (Oxford). 2016 Oct;18(10):793-799. doi: 10.1016/j.hpb.2016.07.009. Epub 2016 Aug 9.

16.

Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma.

Müller SA, Mehrabi A, Rahbari NN, Warschkow R, Elbers H, Leowardi C, Fonouni H, Tarantino I, Schemmer P, Schmied BM, Büchler MW.

Ann Surg Oncol. 2014 Jan;21(1):155-64. doi: 10.1245/s10434-013-3226-9. Epub 2013 Aug 28.

PMID:
23982253
17.

Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.

Kim YS, Hwang IG, Park SE, Go SI, Kang JH, Park I, Oh SY, Ji JH, Song HN, Park SH, Kim ST, Park JO.

Cancer Chemother Pharmacol. 2016 May;77(5):979-85. doi: 10.1007/s00280-016-3014-x. Epub 2016 Mar 26.

PMID:
27017615
18.

The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.

Postlewait LM, Squires MH 3rd, Kooby DA, Poultsides GA, Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI, Schmidt CR, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Swords D, Jin LX, Cho CS, Winslow ER, Cardona K, Staley CA, Maithel SK.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S832-9. doi: 10.1245/s10434-015-4724-8. Epub 2015 Jul 9.

PMID:
26156656
19.

Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases?

Paulino Pereira NR, Beks RB, Janssen SJ, Harris MB, Hornicek FJ, Ferrone ML, Schwab JH.

Spine J. 2016 Aug;16(8):951-61. doi: 10.1016/j.spinee.2016.03.043. Epub 2016 Mar 24.

PMID:
27033311
20.

Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.

Sutton JM, Kooby DA, Wilson GC, Squires MH 3rd, Hanseman DJ, Maithel SK, Bentrem DJ, Weber SM, Cho CS, Winslow ER, Scoggins CR, Martin RC 2nd, Kim HJ, Baker JJ, Merchant NB, Parikh AA, Abbott DE, Edwards MJ, Ahmad SA.

J Gastrointest Surg. 2014 Sep;18(9):1575-87. doi: 10.1007/s11605-014-2567-4. Epub 2014 Jun 19.

PMID:
24944151

Supplemental Content

Support Center